Molecular modeling of highly selective CDK1 Inhibitors based on pyrazolo-pyrimidines using 3D-QSAR, docking, and molecular dynamics simulations
PLOS One · 22.06.2026 · 21 (6) · e0350566
DOI: 10.1371/journal.pone.0350566 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 22.06.2026. Verfasst von Muhammad Afaq Tahir und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, university of veterinary and Animal Sciences, Lahore, Pakistan. Hauptthemen laut MEDLINE: Quantitative Structure-Activity Relationship, Molecular Dynamics Simulation, CDC2 Protein Kinase, Pyrimidines. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cyclin-dependent kinase 1 (CDK1) has emerged as a compelling target for anticancer drug development due to its essential role in cell cycle regulation. In this study, a series of pyrazolopyrimidine-based inhibitors was investigated through an integrated computational approach that combined molecular docking, three-dimensional quantitative structure-activity relationship (3D-QSAR) modeling, and molecular dynamics simulations. CoMFA and CoMSIA models were established to elucidate the structural features influencing CDK1 inhibition, demonstrating high reliability with q² and r² values of 0.58 and 0.945, respectively. Docking studies using the crystal structure of CDK1 (PDB ID: 4Y72) revealed key interactions and hotspot residues, such as L83, V18, and D86, which contribute significantly to ligand binding. From a library of 100 in-house compounds, compounds 34 and 37 exhibited strong binding affinities (−12.61 and −12.50 kcal/mol) and were further evaluated through molecular dynamics simulations. The stability of these complexes was supported by RMSD analysis and binding free energy calculations (−94.99 kcal/mol for compound 34). Moreover, ADMET profiling indicated favorable pharmacokinetic properties and synthetic accessibility. These findings offer critical insights into the structural determinants of CDK1 inhibition and support the further development of pyrazolopyrimidine scaffolds as potential anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Sciences, university of veterinary and Animal Sciences, Lahore, Pakistan.
- Department of Pharmacy, Faculty of Pharmaceutical Sciences, Green International University, Lahore, Pakistan.
- Department peadiatric medicine, Fatima memorial hospital, Lahore, Pakistan.
- Department of Chemistry, Faculty of Science, King Khalid University, Abha, Kingdom of Saudi Arabia.
- Department of Pharmacology and Toxicology, Faculty of Medicine, Umm Al-Qura University, Al-Abidiyah, Makkah, Saudi Arabia.
- Health Research Centre, Jazan University, Jazan, Saudi Arabia.
ORCID-Profile: Tahir Ali Chohan, Abdullah R Alzahrani
Zitieren
APA
Tahir, M. A., Chohan, T. A., Qayyum, A., Yahya Abdullah Alzahrani, A., R Alzahrani, A., Ur Rehman, Z., Khan, A., & Ashfaq, K. (2026). Molecular modeling of highly selective CDK1 Inhibitors based on pyrazolo-pyrimidines using 3D-QSAR, docking, and molecular dynamics simulations. PLOS One, 21(6), e0350566. https://doi.org/10.1371/journal.pone.0350566
Vancouver
Tahir MA, Chohan TA, Qayyum A, Yahya Abdullah Alzahrani A, R Alzahrani A, Ur Rehman Z, et al. Molecular modeling of highly selective CDK1 Inhibitors based on pyrazolo-pyrimidines using 3D-QSAR, docking, and molecular dynamics simulations. PLOS One. 2026;21(6):e0350566. doi:10.1371/journal.pone.0350566
BibTeX
@article{Tahir2026,
author = {Tahir, Muhammad Afaq and Chohan, Tahir Ali and Qayyum, Aisha and Yahya Abdullah Alzahrani, Abdullah and R Alzahrani, Abdullah and Ur Rehman, Zia and Khan, Abida and Ashfaq, Khuram},
title = {Molecular modeling of highly selective CDK1 Inhibitors based on pyrazolo-pyrimidines using 3D-QSAR, docking, and molecular dynamics simulations},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {6},
pages = {e0350566},
doi = {10.1371/journal.pone.0350566}
}
EUVIMED